Lakeview Capital Partners »

Portage Biotech shares owned by Lakeview Capital Partners

Quarter-by-quarter ownership of Portage Biotech (PRTG) shares owned by Lakeview Capital Partners from 13F filings

Historical chart of Lakeview Capital Partners investment in Portage Biotech

Tip: Access up to 7 years of quarterly data

All positions including Portage Biotech held by Lakeview Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Portage Biotech by Lakeview Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $388k 213k 1.82
2023-09-30 $446k 213k 2.09
2023-06-30 $746k 213k 3.50

More positions owned by Lakeview Capital Partners

Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Biohaven (BHVN)
Amazon (AMZN)
Listed Fd Tr Shares Lag Cap (OVL)
Ishares Tr Short Treas Bd (SHV)
JPMorgan Chase & Co. (JPM)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Franklin Templeton Etf Tr Ftse Japan Etf (FLJP)
Abrdn Gold Etf Trust Physcl Gold Shs (SGOL)
Alphabet Cap Stk Cl C (GOOG)
Home Depot (HD)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)

View all positions for Lakeview Capital Partners

Top funds holding Portage Biotech

Lakeview Capital Partners
Citadel Advisors
Beacon Investment Advisory Services
Ieq Capital
Dimensional Fund Advisors
Pathstone Holdings
Barclays
Royal Bank of Canada
National Bank Of Canada /fi/
Wells Fargo & Company
CWM
Princeton Global Asset Management
UBS Group

View all funds holding Portage Biotech